ENGLISH :
In October 2002, the Food and Drug Administration approved buprenorphine for use in the treatment of opioid dependence. Successful diffusion, adoption, and implementation of this medication within the treatment field depend in part o[...]
|
|
2 Documents disponibles écrits par cet auteur
ENGLISH : In October 2002, the Food and Drug Administration approved buprenorphine for use in the treatment of opioid dependence. Successful diffusion, adoption, and implementation of this medication within the treatment field depend in part o[...]
G. S. YACOUBIAN ; S. MILLER ; S. PIANIM ; M. KUNZ ; E. ORRICK ; T. LINK ; W. R. PALACIOS ; R. J. PETERS | 2004
PériodiqueA growing body of recent research has identified that "rave" attendees are at high risk for the use of "club drugs," such as 3,4-methylenedioxymeth-amphetamine (MDMA or "ecstasy"). Rave attendees, however, comprise only one of several club-going[...]